Stem-Cell Module for Cytometry System

The stemCXP is intended for in vitro diagnostic use to simultaneously identify and enumerate CD45+ and CD45+/CD34+ dual positive cell populations, which are key indicators found in the blood of leukemia and lymphoma patients. These indicators are used to monitor disease progression and the effectiveness of therapy.

Beckman Coulter's FC 500 CXP flow cytometry system, introduced to the clinical market in 2003, brought this platform from the life science and clinical research segments into the clinical diagnostic laboratory. The system offers a Windows-based interface, along with laboratory information system (LIS) connectivity and expanded quality control functionality.

"The FC500 CXP flow cytometer is quickly becoming the cornerstone for new, easy-to-use IVD [in vitro diagnostics] applications,” stated Bonnie Anderson, vice president of Beckman Coulter's Tranlational Solutions Business Center. "Now, with both stemCXP and tetraCXP, we can provide a high level of automation and simplicity to clinical laboratories doing HIV and stem cell monitoring.”




Related Links:
Beckman Coulter